Home > Insider Trading > Gyre Therapeutics Inc. > Profile

Gyre Therapeutics Inc. (GYRE)

Market is closed

Sector: Pharmaceutical Preparations

Related Insiders

L Rodney Nussbaum, , 2024-08-17
Renate Parry, , 2024-08-17
M. David Epstein, , 2024-08-17

L Rodney Nussbaum, , 2024-08-17
Renate Parry, , 2024-08-17
M. David Epstein, , 2024-08-17
Gordon Carmichael, , 2024-08-17
Songjiang Ma, President, 2024-08-17
Wilson Thomas Eastling, , 2024-08-17
Ying Luo, , 2024-08-17
Ruoyu Chen, Chief Financial Officer, 2024-08-17
Han Ying, Chief Executive Officer, 2024-08-17
Nassim Usman, , 2024-07-01
Weiguo Ye, Chief Operating Officer, 2023-11-23
Gni Usa, Inc., , 2023-11-23
Ltd. Group Gni, , 2023-11-23
C Charles Wu, Chief Executive Officer, 2023-11-23
Ltd Kong Hong Gni, , 2023-10-27
E. Seline Miller, Svp Finance; Interim Cfo & Pao, 2023-09-01
Andrea Hunt, , 2023-09-01
Augustine Lawlor, , 2023-09-01
E. Grant Blouse, Chief Scientific Officer, 2022-08-10
Eddie Williams, Director, 2022-01-07
M.d. Geoffrey Ling, Director, 2022-01-07
B Errol Desouza, Director, 2021-10-05
Y Jeanne Jew, Director, 2021-09-14
Howard Levy, Chief Medical Officer, 2021-08-11
Sharon Tetlow, Director, 2021-07-02
Clinton Musil, Chief Financial Officer, 2021-04-26
P John Richard, Director, 2020-03-13
Veronica Cai, Controller, 2020-03-13
Fletcher Payne, Chief Financial Officer, 2019-09-25
A Stephen Hill, Director, 2018-09-07
Jfl Capital Management, Llc, Other, 2018-07-27
L.p. Mgmt Deerfield, Large Shareholder, Other, 2018-03-21
Deerfield Special Situations Fund, L.p., Large Shareholder, Other, 2018-03-21
E James Flynn, Large Shareholder, Other, 2018-03-21
Deerfield Partners, L.p., Large Shareholder, Other, 2018-03-21
Deerfield Management Company, L.p. (Series C), Large Shareholder, Other, 2018-03-21
E Harold Selick, Director, 2018-01-18
Edwin Madison, Chief Scientific Officer, 2015-12-15
Essex Woodlands Health Ventures Viii, L.l.c., Large Shareholder, 2015-08-31
Essex Woodlands Health Ventures Viii, L.p., Large Shareholder, 2015-08-31
Bvf Investments Llc, Other, 2015-08-21
P L Fund Value Biotechnology, Other, 2015-08-21
P/Il L Partners Bvf, Other, 2015-08-21
Bvf Inc/Il, Other, 2015-08-21
Biotechnology Value Fund Ii Lp, Other, 2015-08-21
Investment 10 Llc, Other, 2015-08-21
N Mark Lampert, Other, 2015-08-21
Jeff Himawan, Large Shareholder, Director, 2015-08-20
R Julia Brown, Director, 2015-08-18
C. Patrick Rock, Secretary, Gc, 2015-08-18
A Charles Blixt, Director, 2015-08-18
K Mauri Hodges, Treasurer, Cfo, 2015-08-18
W Alan Dunton, Director, 2015-08-18
A Alan Musso, Svp, Fin+Admin, Cfo & Treas, 2014-10-21
M. Steven Toler, Vp, Clin Pharm Sciences, 2014-10-21
A. David Hosford, Vp, Clin Dev & Reg Affairs, 2014-01-24
J Peter Barris, Large Shareholder, 2013-12-05
D Scott Sandell, Large Shareholder, 2013-12-05
James M Barrett, Large Shareholder, 2013-12-05
B Mark Skaletsky, Director, 2013-06-10
A Peter Zorn, Svp, Lgl Affrs, Gc & Secretary, 2013-01-18
A Karen Hicks, Vp, Human Resources, 2013-01-18
P Jeffrey Brennan, Svp, Bus. And Comm. Dev. & Cbo, 2013-01-18
Merouane Bencherif, Svp And Senior Scien Fellow, 2013-01-18
Richard C Kramlich, Large Shareholder, 2012-11-20
Steven Burrill, Director, 2012-08-01
Ralph Snyderman, Director, 2012-06-08
Donald J Debethizy, President And Ceo, 2012-05-08
S William Caldwell, Svp - Drug Discovery And Dev., 2011-09-29
C Geoffrey Dunbar, Svp, Clin. Dev. & Reg. Affairs, 2011-03-31

Show All Insiders (70)

Hedge Fund Popularity

Display

Display Share Price

Display Standard Version

Hedge Fund Holdings

Filing Period:

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Camber Capital ManagementNOTE Stephen Dubois	0	$0	-100%	0%

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Usman	$0.47	3,250	Officer, Director	24,541	2022-08-09	Filing
Miller	$0.47	3,250	Officer	6,500	2022-08-09	Filing
Blouse	$0.47	3,250	Officer	9,417	2022-08-09	Filing
Usman	$0.46	3,250	Officer, Director	21,291	2022-02-09	Filing
Miller	$0.46	3,250	Officer	3,250	2022-02-09	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Remaining Holdings	Date	Form 4
Usman	$12.00	3,452	1,636	2024-06-28	Filing
Usman	$15.63	100	1,636	2024-05-01	Filing
Usman	$14.90	5,000	1,736	2024-05-01	Filing
Usman	$13.86	14,900	6,736	2024-05-01	Filing
Usman	$16.15	20,000	1,636	2024-04-01	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Ifp Advisors, Inc	0	$0	0%